News

Small caps round-up: Ceramic Fuel Cells, Cyprotex, AIM Resources

24 April 2008 09:28:00

Ceramic Fuel Cells said net operating cash outflow for the third quarter was A$3.6m, which was A$1m lower than the previous quarter.

Net operating cash outflow for the three quarters from 1 July to 31 March was A$12.9m, an average of A$4.3m per quarter.

Third quarter expenditure on Research and Product Development was lower than the prior quarter and total cash and financial assets at the end of the quarter was A$39.2m.

Pharmaceuticals firm Cyprotex narrowed pre-tax losses to £543,102 in the year ended 31 December from £760,811 last time and said 2008 should be the year in which to prove its business plan. Revenues increased by 3.7% to £3.63m.

"The value of the group's unique technology is clearly recognised through its expanding international customer base. This should bear fruit in the coming months," said chairman Nikolas Sofronis.

Africa-focused miner AIM Resources said it expects to raise its first ore from the Perkoa zinc mine in Burkina Faso in November.

Excavation began on the mine in April and the company now has over 200 staff working on the project, AIM said. It said a site had been prepared for construction of a processing plant, with components expected to arrive in July.

IT consultancy firm Tikit said the encouraging start to the new year has continued into April. "Business activity levels remain high and we are engaged with a number of clients in the specification, sizing and pricing of further projects due to commence in the second half of 2008," said the group.

First quarter revenue grew 144% to $22.7m at Russian internet web portal Rambler Media, with like-for-like sales up 63% year-on-year to $15.1m.

Losses at drug research group Syntopix grew to £966,207 from £770,432 in the six months ended 31 January as R&D costs rose around £178,000 to £668,883.

Bosses remain confident they will be able to raise sufficient additional funds and expect further commercial opportunities in the next 12 months.

Sefton Resources expects an upswing in production levels after its TEG USA unit said four new wells drilled at the Tapia field are now on full time.

Speech recognition group Telephonetics has made a successful start to the year, trading in line with expectations. It is seeing a healthy pipeline of new business with the continued roll out of its hospital results service.

Business supplies group Office2Office performed as expected in the first quarter. The group, which is in the process of acquiring printing technology group TripleArc, added it looks forward to the rest of the year "with confidence".

Veterinary drug distributor Dechra continued to trade in line with expectations with both its pharmaceuticals and services divisions adding to the growth seen in the first half of the financial year.

Dealing software specialist Patsystems signed a deal with Ascot Financial Services Limited to implement and deploy Patsystems technology in Hong Kong. Ascot will be taking a full installation of the Patsystems solution, and will be deploying it to its customers as an ASP model.

Trading in all three of chromium producer Elementis's continuing businesses in 2008 is ahead of last year, continuing the trends seen in the latter half of last year. The board said it expects full year results to be in line with expectations.

All data suppied by Digital Look (15 minute delay)




Risk Warning

There is an extra risk of losing money when shares are bought in some smaller companies including 'Penny Shares'. There is a big difference between the buying price and the selling price of these shares. If they have to be sold immediately, you may get back much less than you paid for them or you may have difficulty in selling them. Past performance is not a reliable indicator of future results. The price may change quickly and it may go down as well as up. You could lose every penny put into a particular share.

The information contained above has been compiled from documented sources which are believed to be reliable but, due to their very nature, are subject to a degree of historical inaccuracy and have not been independently verified and cannot be guaranteed. The pages on this website are provided for information only. City Equities Limited will not accept responsibility for loss incurred by any person or body acting, or refraining from acting, as a result of information and/or opinions given anywhere on this website. Issued by City Equities Limited, Aldermary House, 10-15 Queen Street, London, EC4N 1TY. Registered in England. Registered No. 2742847. Registered Address: Amwell House, 19 Amwell Street, Hoddeson, Herts. EN11 8TS. City Equities Limited is Authorised and regulated by the Financial Services Authority. Registration No. 155051.